KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $39.3 million.

  • Globus Medical's Change in Accured Expenses rose 3388.89% to $39.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.1 million, marking a year-over-year increase of 108191.32%. This contributed to the annual value of $5.0 million for FY2024, which is 7067.2% down from last year.
  • As of Q3 2025, Globus Medical's Change in Accured Expenses stood at $39.3 million, which was up 3388.89% from $14.8 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Change in Accured Expenses registered a high of $39.3 million during Q3 2025, and its lowest value of -$33.9 million during Q1 2024.
  • Moreover, its 5-year median value for Change in Accured Expenses was $4.9 million (2024), whereas its average is $3.8 million.
  • Examining YoY changes over the last 5 years, Globus Medical's Change in Accured Expenses showed a top increase of 23424.1% in 2024 and a maximum decrease of 23986.36% in 2024.
  • Over the past 5 years, Globus Medical's Change in Accured Expenses (Quarter) stood at $10.4 million in 2021, then tumbled by 57.42% to $4.4 million in 2022, then crashed by 177.98% to -$3.5 million in 2023, then skyrocketed by 234.24% to $4.6 million in 2024, then surged by 747.71% to $39.3 million in 2025.
  • Its Change in Accured Expenses stands at $39.3 million for Q3 2025, versus $14.8 million for Q2 2025 and -$28.7 million for Q1 2025.